Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3654)
All Articles published online
|
Feb 27, 2010 (publication date) through Jul 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Morise Z, Sugioka A, Tokoro T, Tanahashi Y, Okabe Y, Kagawa T, Takeura C. Surgery and chemotherapy for intrahepatic cholangiocarcinoma. World J Hepatol 2010; 2(2): 58-64 [PMID: 21160974 DOI: 10.4254/wjh.v2.i2.58] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v2/i2/58.htm |
| Number | Citing Articles |
| 1 |
Premsai Kumar, Rahul Mhaskar, Richard Kim, Daniel Anaya, Jessica Frakes, Sarah Hoffe, Junsung Choi, Bela Kis. Unresectable Intrahepatic Cholangiocarcinoma Treated with Radiation Segmentectomy/Lobectomy Using Yttrium 90-labeled Glass Microspheres. Journal of Clinical and Experimental Hepatology 2022; 12(5): 1259 doi: 10.1016/j.jceh.2022.03.008
|
| 2 |
JENNIFER ZHANG, MICHAEL N. MAVROS, TIMOTHY M. PAWLIK. Clinical Interventional Oncology. 2014; : 98 doi: 10.1016/B978-1-4557-1221-2.00019-2
|
| 3 |
Ting-Ting Pan, Wei Wang, Wei-Dong Jia, Ge-Liang Xu. A single-center experience of sorafenib monotherapy in patients with advanced intrahepatic cholangiocarcinoma. Oncology Letters 2017; 13(5): 2957 doi: 10.3892/ol.2017.5847
|
| 4 |
Mei‐xia Zhang, Wei Gan, Chu‐yu Jing, Su‐su Zheng, Juan Zhang, Hu‐jia Shen, Xin Xu, Jia‐jia Lin, Bo‐heng Zhang, Shuang‐jian Qiu. Overexpression of interleukin‐35 in intrahepatic cholangiocarcinoma is a prognostic indicator after curative resection. Cancer Science 2018; 109(4): 1195 doi: 10.1111/cas.13535
|
| 5 |
Fan Zhang, Lianhong Li, Xingwu Yang, Bo Wang, Jinyao Zhao, Shilun Lu, Xiaotang Yu. Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3’-methyl-4 dimethylaminoazobenzene in rats. Journal of Toxicologic Pathology 2015; 28(2): 79 doi: 10.1293/tox.2014-0047
|
| 6 |
Ali Ramouz, Sadeq Ali-Hasan-Al-Saegh, Saeed Shafiei, Sanam Fakour, Elias Khajeh, Ali Majlesara, Ali Adeliansedehi, Pascal Probst, Christoph Springfeld, De-Hua Chang, Christian Rupp, Carlos Carvalho, Mohammad Golriz, Katrin Hoffmann, Arianeb Mehrabi. Repeat liver resection for recurrent intrahepatic cholangiocarcinoma: meta-analysis. British Journal of Surgery 2022; 109(7): 580 doi: 10.1093/bjs/znac075
|
| 7 |
Yulei Gu, Zhiqiang Zhu, Hui Pei, Dong Xu, Yumin Jiang, Luanluan Zhang, Lili Xiao. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203. Aging 2020; 12(3): 2333 doi: 10.18632/aging.102747
|
| 8 |
Kazunori Tokuda, Yuji Morine, Yu Saito, Shinichiro Yamada, Katsuki Miyazaki, Shoko Yamashita, Shohei Okikawa, Tetsuya Ikemoto, Satoru Imura, Mitsuo Shimada. Effectiveness of repeat surgery for recurrence after primary hepatectomy in patients with intrahepatic cholangiocarcinoma. International Journal of Clinical Oncology 2020; 25(12): 2083 doi: 10.1007/s10147-020-01775-x
|
| 9 |
Atsushi Maeda, Sho Goto, Ryota Iwasaki, Koji Yamada, Mami Murakami, Hiroki Sakai, Takashi Mori. Outcome of Localized Bile Duct Carcinoma in Six Dogs Treated with Liver Lobectomy. Journal of the American Animal Hospital Association 2022; 58(4): 189 doi: 10.5326/JAAHA-MS-7199
|
| 10 |
Shigeru Marubashi, Kunihito Gotoh, Hidenori Takahashi, Hiroaki Ohigashi, Masahiko Yano, Osamu Ishikawa, Masato Sakon. Prediction of the Postoperative Prognosis of Intrahepatic Cholangiocarcinoma (ICC): Importance of Preoperatively-Determined Anatomic Invasion Level and Number of Tumors. Digestive Diseases and Sciences 2014; 59(1): 201 doi: 10.1007/s10620-013-2894-4
|
| 11 |
B. N. Gurmikov, Yu. A. Kovalenko, V. A. Vishnevsky, A. V. Chzhao. Intrahepatic cholangiocellular carcinoma: diagnosis and treatment (review). Annaly khirurgicheskoy gepatologii = Annals of HPB surgery 2019; 23(4): 108 doi: 10.16931/1995-5464.20184108-117
|
| 12 |
Nafis Shafizadeh, Sanjay Kakar. Hepatocellular Carcinoma. Surgical Pathology Clinics 2013; 6(2): 367 doi: 10.1016/j.path.2013.03.007
|
| 13 |
Koh Kitagawa, Kei Moriya, Kosuke Kaji, Soichiro Saikawa, Shinya Sato, Norihisa Nishimura, Tadashi Namisaki, Takemi Akahane, Akira Mitoro, Hitoshi Yoshiji. Atorvastatin Augments Gemcitabine-Mediated Anti-Cancer Effects by Inhibiting Yes-Associated Protein in Human Cholangiocarcinoma Cells. International Journal of Molecular Sciences 2020; 21(20): 7588 doi: 10.3390/ijms21207588
|
| 14 |
Atit Silsirivanit, Norie Araki, Chaisiri Wongkham, Kulthida Vaeteewoottacharn, Chawalit Pairojkul, Kazuhiko Kuwahara, Yoshiki Narimatsu, Hiromichi Sawaki, Hisashi Narimatsu, Seiji Okada, Nobuo Sakaguchi, Sopit Wongkham. CA‐S27: A novel Lewis a associated carbohydrate epitope is diagnostic and prognostic for cholangiocarcinoma. Cancer Science 2013; 104(10): 1278 doi: 10.1111/cas.12222
|
| 15 |
B Le Roy, M Gelli, G Pittau, M -A Allard, B Pereira, B Serji, E Vibert, D Castaing, R Adam, D Cherqui, A Sa Cunha. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma. British Journal of Surgery 2018; 105(7): 839 doi: 10.1002/bjs.10641
|
| 16 |
Seung Hee Ha, Jong-Ho Hwang, Do Hyung Kim, Min-Dae Kim, Cheol-Woong Choi, Young-Il Jeong, Chung Wook Chung, Cy Hyun Kim, Dae Hwan Kang. Sunitinib release from biodegradable films of poly(l-lactide-co-caprolactone). Materials Research Bulletin 2012; 47(10): 2735 doi: 10.1016/j.materresbull.2012.04.125
|
| 17 |
Bryan Doherty, Vinod E. Nambudiri, William C. Palmer. Update on the Diagnosis and Treatment of Cholangiocarcinoma. Current Gastroenterology Reports 2017; 19(1) doi: 10.1007/s11894-017-0542-4
|
| 18 |
Hanisah Guro, Jin Won Kim, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches. Surgical Oncology 2017; 26(2): 146 doi: 10.1016/j.suronc.2017.03.001
|
| 19 |
B.N. Gurmikov, V.A. Vishnevsky, Yu.A. Kovalenko, A.V. Chzhao. Long-term results of surgical treatment of intrahepatic cholangiocarcinoma. Khirurgiya. Zhurnal im. N.I. Pirogova 2020; (5): 5 doi: 10.17116/hirurgia20200515
|
| 20 |
Xiangji Luo, Weidong Jia, Zhiyong Huang, Xiangcheng Li, Baocai Xing, Xiaoqing Jiang, Jun Li, Anfeng Si, Tian Yang, Chunfang Gao, Wan Yee Lau, Feng Shen. Effectiveness and safety of sorafenib in the treatment of unresectable and advanced intrahepatic cholangiocarcinoma: a pilot study. Oncotarget 2017; 8(10): 17246 doi: 10.18632/oncotarget.12825
|
| 21 |
Li-Ye Wang, Shuai Gong, Li-Ping Gao, Li-Xia Hou, Wei He. Apatinib for treating advanced intrahepatic cholangiocarcinoma after failed chemotherapy. Medicine 2018; 97(49): e13372 doi: 10.1097/MD.0000000000013372
|
| 22 |
Weiping Chang, Yuan Wang, WenZhi Li, Zhimin Geng. Long non‐coding RNA myocardial infarction associated transcript promotes the proliferation of cholangiocarcinoma cells by targeting miR‐551b‐3p/CCND1 axis. Clinical and Experimental Pharmacology and Physiology 2020; 47(6): 1067 doi: 10.1111/1440-1681.13283
|
| 23 |
Ruethairat Sriraksa, Temduang Limpaiboon. TRAIL in Combination with Subtoxic 5-FU Effectively Inhibit Cell Proliferation and Induce Apoptosis in Cholangiocarcinoma Cells. Asian Pacific Journal of Cancer Prevention 2015; 16(16): 6991 doi: 10.7314/APJCP.2015.16.16.6991
|
| 24 |
Sameer H. Patel, David A. Kooby, Charles A. Staley, Juan M. Sarmiento, Shishir K. Maithel. The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy?. HPB 2011; 13(9): 605 doi: 10.1111/j.1477-2574.2011.00335.x
|
| 25 |
Paulina Chinchilla-López, Nancy E. Aguilar-Olivos, Jaime García-Gómez, Karen K. Hernández-Alejandro, Fredy Chablé-Montero, Daniel Motola-Kuba, Tushar Patel, Nahum Méndez-Sánchez. Prevalence, Risk Factors, and Survival of Patients with Intrahepatic Cholangiocarcinoma. Annals of Hepatology 2017; 16(4): 565 doi: 10.5604/01.3001.0010.0293
|
| 26 |
Kulthida Vaeteewoottacharn, Ryusho Kariya, Kouki Matsuda, Manabu Taura, Chaisiri Wongkham, Sopit Wongkham, Seiji Okada. Perturbation of proteasome function by bortezomib leading to ER stress-induced apoptotic cell death in cholangiocarcinoma. Journal of Cancer Research and Clinical Oncology 2013; 139(9): 1551 doi: 10.1007/s00432-013-1473-6
|
| 27 |
SHUAI LI, ZHIYANG HAN, YONG MA, RUIPENG SONG, TIEMIN PEI, TONGSEN ZHENG, JIABEI WANG, DONGSHENG XU, XIANG FANG, HONGCHI JIANG, LIANXIN LIU. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study. Oncology Reports 2014; 31(1): 145 doi: 10.3892/or.2013.2853
|
| 28 |
Shiwei Liu, Lei Zhou, Lin An. Implementation of comprehensive rehabilitation therapy in postoperative care of patients with cholangiocarcinoma and its impact on patients' quality of life. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7215
|
| 29 |
Wenli Xie, Ling Wei, Jing Guo, Hui Guo, Xianrang Song, Xiugui Sheng. Physiological functions of Wilms’ tumor 1‐associating protein and its role in tumourigenesis. Journal of Cellular Biochemistry 2019; 120(7): 10884 doi: 10.1002/jcb.28402
|
| 30 |
Ze Qian, Wendi Hu, Zhen Lv, Hua Liu, Diyu Chen, Yacong Wang, Jian Wu, Shusen Zheng. PKM2 upregulation promotes malignancy and indicates poor prognosis for intrahepatic cholangiocarcinoma. Clinics and Research in Hepatology and Gastroenterology 2020; 44(2): 162 doi: 10.1016/j.clinre.2019.06.008
|
| 31 |
Mutita Junking, Janya Grainok, Chutamas Thepmalee, Sopit Wongkham, Pa-thai Yenchitsomanus. Enhanced cytotoxic activity of effector T-cells against cholangiocarcinoma by dendritic cells pulsed with pooled mRNA. Tumor Biology 2017; 39(10): 101042831773336 doi: 10.1177/1010428317733367
|
| 32 |
John Bridgewater, Peter R. Galle, Shahid A. Khan, Josep M. Llovet, Joong-Won Park, Tushar Patel, Timothy M. Pawlik, Gregory J. Gores. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. Journal of Hepatology 2014; 60(6): 1268 doi: 10.1016/j.jhep.2014.01.021
|
| 33 |
Rhonda K. Yantiss. Frozen Section Library: Liver, Extrahepatic Biliary Tree and Gallbladder. Frozen Section Library 2011; : 21 doi: 10.1007/978-1-4614-0043-1_2
|
| 34 |
Chi Zhang, Dou-Sheng Bai, Xiao-Yong Huang, Guo-Ming Shi, Ai-Wu Ke, Liu-Xiao Yang, Xin-Rong Yang, Jian Zhou, Jia Fan, Kwan Man. Prognostic Significance of Capn4 Overexpression in Intrahepatic Cholangiocarcinoma. PLoS ONE 2013; 8(1): e54619 doi: 10.1371/journal.pone.0054619
|
| 35 |
Ka Wing Ma, Tan To Cheung, Brian Leung, Brian Wong Hoi She, Kenneth Siu Ho Chok, Albert Chi Yan Chan, Wing Chiu Dai, Chung Mau Lo. Adjuvant chemotherapy improves oncological outcomes of resectable intrahepatic cholangiocarcinoma. Medicine 2019; 98(5): e14013 doi: 10.1097/MD.0000000000014013
|
| 36 |
XIAO-PING TAN, QING ZHANG, WEI-GUO DONG, XIA-WEN LEI, ZI-RONG YANG. Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance. Oncology Letters 2012; 3(5): 1037 doi: 10.3892/ol.2012.620
|
| 37 |
Prajnan Das, Mirna T. Abboud, Waqar Haque, Milind Javle, Ahmed Kaseb, Steven A. Curley, Jean-Nicolas Vauthey, Thomas A. Aloia, A. Sam Beddar, Marc E. Delclos, Sunil Krishnan, Christopher H. Crane. Gastric bleeding after radiation therapy for intrahepatic cholangiocarcinoma. Practical Radiation Oncology 2013; 3(4): 344 doi: 10.1016/j.prro.2012.11.001
|
| 38 |
Qianqian Zhao, Yixing Chen, Shisuo Du, Xinrong Yang, Yanling Chen, Yuan Ji, Zhaochong Zeng. Integration of radiotherapy with anti-PD-1 antibody for the treatment of intrahepatic or hilar cholangiocarcinoma: reflection from four cases. Cancer Biology & Therapy 2021; 22(3): 175 doi: 10.1080/15384047.2020.1834792
|
| 39 |
Xiao-xue Zhang, Hong-bin Ma, Tie-hua Li, Bin Huang, Ning-yang Jia, Yan Meng. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma. Clinical and Translational Oncology 2022; 25(3): 731 doi: 10.1007/s12094-022-02979-5
|
| 40 |
Young-Il Kim, Joong-Won Park, Bo Hyun Kim, Sang Myung Woo, Tae Hyun Kim, Young Hwan Koh, Woo Jin Lee, Chang-Min Kim. Outcomes of concurrent chemoradiotherapy versus chemotherapy alone for advanced-stage unresectable intrahepatic cholangiocarcinoma. Radiation Oncology 2013; 8(1) doi: 10.1186/1748-717X-8-292
|
| 41 |
Kimberly M. Brown, Abhishek D. Parmar, David A. Geller. Intrahepatic Cholangiocarcinoma. Surgical Oncology Clinics of North America 2014; 23(2): 231 doi: 10.1016/j.soc.2013.10.004
|
| 42 |
Sophia K. McKinley, Akhil Chawla, Cristina R. Ferrone. Inoperable Biliary Tract and Primary Liver Tumors. Surgical Oncology Clinics of North America 2019; 28(4): 745 doi: 10.1016/j.soc.2019.06.009
|
| 43 |
Chao Wang, Baoyue Zhang, Runmei Peng, Zan Zuo, Hongzhong Cheng, Jun Zhu, Tianxing Chen, Zhengji Song. Cholangiocarcinoma presenting as dysphagia and misdiagnosed as gastritis: a case report. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02156-6
|
| 44 |
William C. Palmer, Denise M. Harnois. Complications of Cirrhosis. 2015; : 219 doi: 10.1007/978-3-319-13614-1_23
|
| 45 |
Shi-qi Huang, Han-ming Zhang, Yi-cong Zhang, Lu-yao Wang, Zhi-rong Zhang, Ling Zhang. Comparison of two methods for tumour-targeting peptide modification of liposomes. Acta Pharmacologica Sinica 2023; 44(4): 832 doi: 10.1038/s41401-022-01011-4
|
| 46 |
C.S. van Kessel, M.S. van Leeuwen, R. van Hillegersberg, I.H.M. Borel Rinkes, M.A.A.J. van den Bosch, I.Q. Molenaar. Patient Tailored Resection Planning in Patients Undergoing Liver Surgery for Colorectal Liver Metastases; How and Why Should You Do It?. Journal of Gastrointestinal Surgery 2013; 17(10): 1836 doi: 10.1007/s11605-013-2185-6
|
| 47 |
Eun Jeong Lee, Hyun Woo Chung, Joon-Hyung Jo, Young So. Radioembolization for the Treatment of Primary and Metastatic Liver Cancers. Nuclear Medicine and Molecular Imaging 2019; 53(6): 367 doi: 10.1007/s13139-019-00615-9
|